Description
Nobivac® RL
Reg. No. G2199 (Act 36/1947)
Namibia Reg. No. V97/24.1/891 [NS0]
Suspension for injection for dogs
Only for use by or under the supervision of persons registered in terms of, or authorised in terms of, Section 23 (1) (c) of the Veterinary and Para-Veterinary Professions Act, 1982 (Act 19 of 1982).
Rabies is a controlled disease in terms of the Animal Diseases Act (Act 35 of 1984). The occurrence or suspicion of this disease must be reported to the responsible state veterinarian immediately.
INDICATIONS
Nobivac® RL is an inactivated vaccine for the active immunisation of healthy dogs against rabies and canine leptospirosis, caused by Leptospira interrogans serogroups Canicola and Icterohaemorrhagiae.
COMPOSITION
Each 1 mℓ dose of Nobivac® RL contains at least 3 IU of rabies virus strain Pasteur RIV, as measured in the mouse potency test, grown on cell culture and inactivated with BPL, as well as BPL-inactivated Leptospira interrogans serogroup Canicola, strain Ca-12-000 ≥ 40 hamster PD80 and serogroup Icterohaemorrhagiae, strain 820K ≥ 40 hamster PD80 with
2 % aluminium phosphate as an adjuvant.
